Chemours Hits New 52-Week High, Analysts Weigh In

The specialty chemicals company's stock price reached a new 12-month peak, sparking debate on whether it's time to buy.

Apr. 8, 2026 at 2:10pm

Got story updates? Submit your updates here. ›

Shares of The Chemours Company (NYSE:CC) reached a new 52-week high of $22.80 during mid-day trading on Wednesday, closing at $21.01 with 9,970 shares traded. Wall Street analysts have issued a range of ratings on the stock, from 'Buy' to 'Sell', with an average price target of $18.40.

Why it matters

Chemours' stock performance is closely watched as an indicator of the broader specialty chemicals industry. The company's ability to hit new highs despite a challenging economic environment suggests potential upside, though analysts remain divided on the stock's future prospects.

The details

Chemours, which was spun off from DuPont in 2015, has seen its stock price rise steadily in recent months. The company reported Q4 2025 earnings of $0.05 per share, beating analyst estimates of $0.01. Revenue for the quarter was $1.33 billion, down 2.2% year-over-year. Chemours also pays a quarterly dividend of $0.0875 per share.

  • Chemours stock reached a new 52-week high on Wednesday, April 8, 2026.
  • The company reported Q4 2025 earnings on Thursday, February 19, 2026.

The players

Chemours

The Chemours Company is a global chemistry organization headquartered in Wilmington, Delaware. The company was established in 2015 as a spin-off from E. I. du Pont de Nemours and Company.

Jefferies Financial Group

An investment banking firm that has issued a 'hold' rating on Chemours stock with a $17.00 price target.

Weiss Ratings

A financial research firm that has issued a 'sell (d)' rating on Chemours stock.

Royal Bank of Canada

A bank that has issued an 'outperform' rating on Chemours stock with a $18.00 target price.

UBS Group

A financial services firm that has increased its target price on Chemours stock from $18.00 to $23.00 and maintained a 'buy' rating.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

What’s next

Analysts will continue to monitor Chemours' financial performance and provide updated ratings and price targets as the company navigates the evolving specialty chemicals market.

The takeaway

Chemours' ability to hit new 52-week highs suggests potential upside, but Wall Street remains divided on the stock's future prospects given the company's exposure to macroeconomic factors and industry dynamics.